Literature DB >> 36006590

Eradicating Atherosclerosis: Should We Start Statins at Younger Ages and at Lower LDL-Cs.

Thomas O'Toole1, Michelle D Kelsey2,3, Nishant P Shah2,3, Robert W McGarrah2, Neha J Pagidipati2,3.   

Abstract

PURPOSE OF REVIEW: Given the increasing burden of cardiovascular disease, we review the literature for earlier initiation of statin therapy at younger ages and lower low-density lipoprotein cholesterol (LDL-C) levels, with the goal of preventing the development of atherosclerosis prior to clinical events. RECENT
FINDINGS: There is a rising prevalence of dyslipidemia among younger adults. Although guidelines offer recommendations for adults over 40, there is little guidance for the management of younger adults with moderately elevated LDL-C levels. Earlier and more aggressive statin use may slow progression, or even halt atherosclerosis, and may likewise be beneficial and cost-effective on a population level. Further research is needed to define the exact age and LDL-C level at which to start statin therapy. Until then, more detailed risk stratification with lab testing and imaging should be used to identify younger adults at the highest risk.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Atherosclerotic cardiovascular disease; Low density lipoprotein cholesterol; Primary prevention; Primordial prevention; Statin

Mesh:

Substances:

Year:  2022        PMID: 36006590     DOI: 10.1007/s11886-022-01760-y

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   3.955


  55 in total

1.  Risk of Premature Cardiovascular Disease vs the Number of Premature Cardiovascular Events.

Authors:  Allan D Sniderman; George Thanassoulis; Ken Williams; Michael Pencina
Journal:  JAMA Cardiol       Date:  2016-07-01       Impact factor: 14.676

2.  Long-Term Association of Low-Density Lipoprotein Cholesterol With Cardiovascular Mortality in Individuals at Low 10-Year Risk of Atherosclerotic Cardiovascular Disease.

Authors:  Shuaib M Abdullah; Laura F Defina; David Leonard; Carolyn E Barlow; Nina B Radford; Benjamin L Willis; Anand Rohatgi; Darren K McGuire; James A de Lemos; Scott M Grundy; Jarett D Berry; Amit Khera
Journal:  Circulation       Date:  2018-11-20       Impact factor: 29.690

3.  2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Scott M Grundy; Neil J Stone; Alison L Bailey; Craig Beam; Kim K Birtcher; Roger S Blumenthal; Lynne T Braun; Sarah de Ferranti; Joseph Faiella-Tommasino; Daniel E Forman; Ronald Goldberg; Paul A Heidenreich; Mark A Hlatky; Daniel W Jones; Donald Lloyd-Jones; Nuria Lopez-Pajares; Chiadi E Ndumele; Carl E Orringer; Carmen A Peralta; Joseph J Saseen; Sidney C Smith; Laurence Sperling; Salim S Virani; Joseph Yeboah
Journal:  Circulation       Date:  2018-11-10       Impact factor: 29.690

4.  National lipid association recommendations for patient-centered management of dyslipidemia: part 1--full report.

Authors:  Terry A Jacobson; Matthew K Ito; Kevin C Maki; Carl E Orringer; Harold E Bays; Peter H Jones; James M McKenney; Scott M Grundy; Edward A Gill; Robert A Wild; Don P Wilson; W Virgil Brown
Journal:  J Clin Lipidol       Date:  2015-04-07       Impact factor: 4.766

5.  Time Course of LDL Cholesterol Exposure and Cardiovascular Disease Event Risk.

Authors:  Michael J Domanski; Xin Tian; Colin O Wu; Jared P Reis; Amit K Dey; Yuan Gu; Lihui Zhao; Sejong Bae; Kiang Liu; Ahmed A Hasan; David Zimrin; Michael E Farkouh; Charles C Hong; Donald M Lloyd-Jones; Valentin Fuster
Journal:  J Am Coll Cardiol       Date:  2020-09-29       Impact factor: 24.094

6.  2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Donna K Arnett; Roger S Blumenthal; Michelle A Albert; Andrew B Buroker; Zachary D Goldberger; Ellen J Hahn; Cheryl Dennison Himmelfarb; Amit Khera; Donald Lloyd-Jones; J William McEvoy; Erin D Michos; Michael D Miedema; Daniel Muñoz; Sidney C Smith; Salim S Virani; Kim A Williams; Joseph Yeboah; Boback Ziaeian
Journal:  J Am Coll Cardiol       Date:  2019-03-17       Impact factor: 24.094

7.  2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk.

Authors:  François Mach; Colin Baigent; Alberico L Catapano; Konstantinos C Koskinas; Manuela Casula; Lina Badimon; M John Chapman; Guy G De Backer; Victoria Delgado; Brian A Ference; Ian M Graham; Alison Halliday; Ulf Landmesser; Borislava Mihaylova; Terje R Pedersen; Gabriele Riccardi; Dimitrios J Richter; Marc S Sabatine; Marja-Riitta Taskinen; Lale Tokgozoglu; Olov Wiklund
Journal:  Eur Heart J       Date:  2020-01-01       Impact factor: 29.983

8.  Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel.

Authors:  Jan Borén; M John Chapman; Ronald M Krauss; Chris J Packard; Jacob F Bentzon; Christoph J Binder; Mat J Daemen; Linda L Demer; Robert A Hegele; Stephen J Nicholls; Børge G Nordestgaard; Gerald F Watts; Eric Bruckert; Sergio Fazio; Brian A Ference; Ian Graham; Jay D Horton; Ulf Landmesser; Ulrich Laufs; Luis Masana; Gerard Pasterkamp; Frederick J Raal; Kausik K Ray; Heribert Schunkert; Marja-Riitta Taskinen; Bart van de Sluis; Olov Wiklund; Lale Tokgozoglu; Alberico L Catapano; Henry N Ginsberg
Journal:  Eur Heart J       Date:  2020-06-21       Impact factor: 29.983

9.  Performance of Guideline Recommendations for Prevention of Myocardial Infarction in Young Adults.

Authors:  Michel Zeitouni; Michael G Nanna; Jie-Lena Sun; Karen Chiswell; Eric D Peterson; Ann Marie Navar
Journal:  J Am Coll Cardiol       Date:  2020-08-11       Impact factor: 27.203

10.  Relations of change in plasma levels of LDL-C, non-HDL-C and apoB with risk reduction from statin therapy: a meta-analysis of randomized trials.

Authors:  George Thanassoulis; Ken Williams; Keying Ye; Robert Brook; Patrick Couture; Patrick R Lawler; Jacqueline de Graaf; Curt D Furberg; Allan Sniderman
Journal:  J Am Heart Assoc       Date:  2014-04-14       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.